US equities |
NVDA $239.67 ▲+0.32% MU $1,053.23 ▼-1.01% SPCX $172.56 ▲+0.86% MRVL $290.65 ▲+7.15% AMD $653.95 ▲+3.51% INTC $114.02 ▼-1.87% AVGO $376.95 ▲+3.98% TSLA $379.92 ▲+0.31%
FinancialContent

Integra LifeSciences Holdings Corporation - Common Stock (NQ:IART)

13.21 -0.07 (-0.56%)
Delayed Quote Updated: 3:22 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Integra LifeSciences Holdings Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
3 Profitable Stocks with Questionable Fundamentals
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
News headline image
3 Reasons to Sell IART and 1 Stock to Buy Instead
Since July 2025, Integra LifeSciences has been in a holding pattern, posting a small loss of 4% while floating around $12.25. The stock also fell short of the S&P 500’s 9.9% gain during that period. 
Via StockStory
Topics Stocks
News headline image
3 of Wall Street’s Favorite Stocks with Open Questions
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
News headline image
3 Volatile Stocks That Fall Short
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced... 
Via StockStory
News headline image
Earnings Scheduled For October 30, 2025 ↗
 
Via Benzinga
News headline image
Integra LifeSciences, Evolent Health, Incyte, iRhythm, and Clover Health Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after a report revealed that the White House plans to pitch a two-year extension of Obamacare subsidies. 
Via StockStory
Topics Economy
News headline image
Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy
News headline image
1 Small-Cap Stock with Promising Prospects and 2 That Underwhelm
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
News headline image
Surgical Equipment & Consumables - Specialty Stocks Q3 Recap: Benchmarking Integra LifeSciences (NASDAQ:IART)
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - specialty stocks, including Integra LifeSciences (NASDAQ:IART) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Integra LifeSciences (IART) Stock Trades Up, Here Is Why
Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 1.7% in the afternoon session after the company received U.S. FDA 510(k) clearance for its CUSA Clarity Ultrasonic Surgical... 
Via StockStory
News headline image
3 of Wall Street’s Favorite Stocks We Keep Off Our Radar
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
News headline image
5 Must-Read Analyst Questions From Integra LifeSciences’s Q3 Earnings Call
Integra LifeSciences’ third quarter was marked by operational disruptions and underwhelming revenue growth, resulting in a significant negative market reaction. Management attributed the revenue... 
Via StockStory
Topics Earnings Economy
News headline image
Why Integra LifeSciences (IART) Shares Are Trading Lower Today
Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 5.7% in the afternoon session after the stock's negative momentum continued as the company reported weak third-quarter results... 
Via StockStory
News headline image
IART Q3 Deep Dive: Supply Chain Progress, Product Relaunches, and Margin Pressures Shape Outlook
Medical device company Integra LifeSciences (NASDAQ:IART) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 5.6% year on year to $402.1 million. Next quarter’s revenue guidance of... 
Via StockStory
Topics Economy World Trade
News headline image
Why Integra LifeSciences (IART) Shares Are Sliding Today
Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 23% in the morning session after it reported third-quarter sales that missed expectations and provided a weak financial outlook.... 
Via StockStory
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
The market is filled with gapping stocks in Thursday's session. ↗
Today's session on Thursday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Integra LifeSciences (NASDAQ:IART) Posts Mixed Q3 2025 Results with EPS Beat and Revenue Miss ↗
Integra LifeSciences (IART) posted mixed Q3 2025 results, beating earnings estimates by 21.7% but missing revenue targets. The stock rose on the profit beat despite soft forward guidance. 
Via Chartmill
News headline image
Integra LifeSciences (NASDAQ:IART) Misses Q3 Sales Expectations
Medical device company Integra LifeSciences (NASDAQ:IART) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 5.6% year on year to $402.1 million. Next quarter’s revenue guidance of... 
Via StockStory
News headline image
Integra LifeSciences (IART) Q3 Earnings Report Preview: What To Look For
Medical device company Integra LifeSciences (NASDAQ:IART) will be reporting results this Thursday before market open. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
News headline image
2 Stocks Under $50 for Long-Term Investors and 1 We Question
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
News headline image
Sanara MedTech Inc. Navigates Market Downturn Amidst "Undervalued" Consensus and Strategic Shifts
Dallas, TX – October 17, 2025 – Sanara MedTech Inc. (NASDAQ: SMTI), a company focused on surgical and chronic wound care, finds itself in the spotlight today as a bottom market performer, with its... 
Via MarketMinute
News headline image
Organogenesis Holdings (ORGO) Battles Headwinds: Can This Regenerative Medicine Innovator Stage a Comeback?
Canton, MA – Organogenesis Holdings Inc. (NASDAQ: ORGO), a prominent player in the regenerative medicine sector, has recently endured a period of significant stock weakness, leaving investors... 
Via MarketMinute
Topics Fraud
News headline image
Why Integra LifeSciences (IART) Shares Are Trading Lower Today
Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell in the afternoon session after Truist kept a Hold rating on the shares. The analyst mentioned in a research note that they... 
Via StockStory
Topics Artificial Intelligence Economy Government
News headline image
Integra LifeSciences, Inspire Medical Systems, Merit Medical Systems, Enovis, and CONMED Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
News headline image
3 Healthcare Stocks We Think Twice About
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the... 
Via StockStory
Topics Stocks
News headline image
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is... 
Via StockStory
Topics Government World Trade
News headline image
3 Reasons to Sell IART and 1 Stock to Buy Instead
Integra LifeSciences’s stock price has taken a beating over the past six months, shedding 39.3% of its value and falling to $13.34 per share. This might have investors contemplating their next move. 
Via StockStory
News headline image
Integra LifeSciences and LeMaitre Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential... 
Via StockStory
Topics World Trade
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >